Business Context and Reporting Period
This Form 6-K filing is submitted by Galapagos NV, a foreign private issuer, for the month of October 2018. The filing, dated October 25, 2018, serves to incorporate by reference a press release issued on October 24, 2018 (Exhibit 99.1). The registrant is incorporated in Belgium and files annual reports on Form 20-F. Note: The request metadata references "Lakefront Biotherapeutics NV," but the filing text explicitly identifies the registrant as Galapagos NV.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a procedural filing designed to distribute a press release and does not include revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing text does not disclose specific material changes in financial position or operations. It solely references the issuance of a press release on October 24, 2018, the content of which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It states that the press release is incorporated into various Registration Statements (Forms F-3 and S-8) but does not summarize the content of that release.
Investor Verification Checklist
- Verify the content of the press release dated October 24, 2018 (Exhibit 99.1), as the filing text only references it without summarizing it.
- Confirm the registrant identity is Galapagos NV, not Lakefront Biotherapeutics NV, based on the official filing header.
- Review the referenced Registration Statements (File Nos. 333-211765, 333-204567, etc.) for context on how the press release impacts outstanding securities.
- Check subsequent filings for the actual financial metrics and operational updates likely detailed in the omitted press release.